Exploring the Pharmacological Landscape of Undaria pinnatifida: Insights into Neuroprotective Actions and Bioactive Constituents
The marine seaweed Undaria pinnatifida belongs to the large group of brown macroalgae (Ochrophyta) and is valued both as a nutritious food and a source of pharmaceutical compounds. It has been widely consumed in East Asia as part of the traditional diet and is generally regarded as a “healthy longevity food.” Consequently, it represents one of the most promising natural sources of biomedicinal and bioactive products. This review aims to synthesize current scientific evidence on the pharmacologically active compounds of U. pinnatifida, emphasizing their mechanisms of action and therapeutic potential in neurodegenerative and chronic diseases. This narrative review is based on a comprehensive literature search of peer-reviewed articles from scientific databases, focusing on studies addressing the pharmacological properties of U. pinnatifida and its major bioactive constituents. Recent research highlights that compounds such as fucoxanthin (a carotenoid), fucosterol (a sterol), fucoidan (a polysaccharide), alginate, and dietary fiber found in U. pinnatifida possess significant potential for developing treatments for conditions including goitre, urinary diseases, scrofula, dropsy, stomach ailments, and hemorrhoids. Moreover, these compounds exhibit remarkable pharmacological properties, including immunomodulation, antitumor, antiviral, antioxidant, antidiabetic, anti-inflammatory, anticoagulant, antithrombotic, and antibacterial activities, all with low toxicity and minimal side effects. Additionally, U. pinnatifida shows promise in the treatment or prevention of neurodegenerative diseases such as Alzheimer’s and Parkinson’s, as well as neuropsychiatric conditions like depression, supported by its antioxidant effects against oxidative stress and neuroprotective activities. Numerous in vitro and in vivo studies have confirmed that U. pinnatifida polysaccharides (UPPs), particularly fucoidans, exhibit significant biological activities. Thus, accumulating evidence positions UPPs as promising therapeutic agents for a variety of diseases.
Authors
- Jorge Magalhães Rodrigues (ORCID: https://orcid.org/0000-0001-5892-1855)
- C.H.F. Alves (ORCID: https://orcid.org/0009-0007-0393-5142)
- Cristina Soares (ORCID: https://orcid.org/0000-0003-0924-9681)
- Clara Grosso (ORCID: https://orcid.org/0000-0002-2457-8267)
- Jorge Machado (ORCID: https://orcid.org/0000-0003-4570-5445)
- Maria Begoña Criado (ORCID: https://orcid.org/0000-0003-1750-5614)
- Helena Machado (ORCID: https://orcid.org/0009-0000-5170-9325)
Institutions
- Universidade do Porto (PT)
- Cooperativa de Ensino Superior Politécnico e Universitário (PT)
- Rede de Química e Tecnologia (PT)
- Unidade em Ciências Biomoleculares Aplicadas
- Polytechnic Institute of Porto (PT)
Publication Details
- Journal
- Nutraceuticals
- Published
- 2025-07-24
- DOI
- https://doi.org/10.3390/nutraceuticals5030020
- Citations
- 2
- Primary Topic
- Seaweed-derived Bioactive Compounds
- Type
- article
- Field-Weighted Citation Impact
- 4.55